جست‌وجوی استاد و پژوهشگر

• Virology
• Immunology
• Animal Health
• +۵ مورد دیگر

Jan Paeshuyse serves as an Associate Professor in the Department of Biosystems within KU Leuven's Faculty of Bioscience Engineering, where he leads the Animal and Human Health Engineering (A2H) research group. He chairs the Biosafety Committee and holds key memberships in the Animal Ethics Commission, Faculty Council, and Department Council, reflecting his institutional leadership in biosafety and ethical oversight of animal research. His research centers on Host-Pathogen Interactions in Livestock , with specialized focus on molecular virology of pestiviruses and development of therapeutics, vaccines, and immune modulators . Core methodologies integrate One Health principles across: Virology and immunopathology of livestock diseases CRISPR-based and phage-derived diagnostic platforms In-silico vaccine design and immunobiotechnology Eco-epidemiology of zoonotic pathogens in pastoral communities Recent publications reveal intensive fieldwork in Ethiopia targeting lumpy skin disease, Rift Valley fever, and bovine viral diarrhea, with growing emphasis on computational vaccinology and microbiome-host interactions. Over 60% of his 2024-2025 output addresses livestock health challenges in resource-limited settings through interdisciplinary collaborations. Professor Paeshuyse actively supervises doctoral candidates including Regassa, Megersa, Lyimu, and Jacobs, while directing eight major grants totaling over €2.3M in funding. Current projects span: Vaccine development for poultry pathogens (Ethiopia) Diagnostic kits for lumpy skin disease Immuno-nutritional strategies for livestock Duck hepatitis B models for human therapeutics He co-leads KU Leuven's One Health Institute, driving cross-faculty initiatives that bridge veterinary science, human medicine, and environmental health through the A2H research cluster.

Viktoria Weberمشاهده پروفایل

استاد

• Applied Biochemistry
• Glycobiology
• Extracellular Vesicles
• +۷ مورد دیگر

Viktoria Weber is a full Professor of Applied Biochemistry and Vice-Rector for Research at Danube University Krems, where she also leads the Department for Biomedical Research and the Christian Doppler Laboratory for Innovative Therapy Approaches in Sepsis. She previously conducted research at the Medical University of Vienna and holds a PhD and habilitation in glycobiology from the University of Natural Resources and Life Sciences, Vienna. PhD in Glycobiology, University of Natural Resources and Life Sciences, Vienna Habilitation, University of Natural Resources and Life Sciences, Vienna Degree in Biotechnology, University of Natural Resources and Life Sciences, Vienna Her research focuses on cellular activation at the blood-biomaterial interface, extracellular vesicles in thrombogenesis and immunomodulation, and advanced diagnostics for sepsis and bloodstream infections. She integrates biochemical, immunological, and clinical approaches to understand host responses in extracorporeal circuits and infectious disease. The recent publication trends highlight consistent contributions in extracellular vesicles , sepsis , immunothrombosis , and biomaterial compatibility . These works span molecular mechanisms to translational diagnostics, reflecting a strong emphasis on bridging basic science with clinical applications in critical care and biomedical engineering. She holds leadership roles in major scientific organizations: Co-founder and Vice President, Austrian Society for Extracellular Vesicles Vice President, Austrian Association for Molecular Life Sciences and Biotechnology Board Member, European Society for Artificial Organs She advises national and international funding agencies as an expert reviewer and leads multidisciplinary research teams focused on sepsis therapy and blood-biomaterial interactions. Her department hosts collaborative projects in biomedical detection systems and innovative treatment strategies. She also oversees research strategy as Vice-Rector, supporting institutional scientific development. Her research is conducted within the Christian Doppler Laboratory for Innovative Therapy Approaches in Sepsis and the Department for Biomedical Research, which foster interdisciplinary collaboration between biochemists, clinicians, and engineers to develop novel diagnostic and therapeutic solutions.

• Nanomedicine
• Drug Delivery Systems
• Pharmaceutical Technology
• +۴ مورد دیگر

Noemi Stefanía Csaba is a Professor at the University of Santiago de Compostela, affiliated with the Department of Pharmacology, Pharmacy and Pharmaceutical Technology within the Faculty of Pharmacy. She is also part of the Center for Research in Molecular Medicine and Chronic Diseases (CIMUS). Her research focuses on nanotechnologies applied to drug delivery systems, particularly in the development of gene therapy carriers, vaccines, and targeted therapies for cancer and infectious diseases. She earned her PhD in 2005 with a thesis on genetic vaccine delivery systems under the supervision of Dr. María José Alonso Fernández and Dr. Alejandro Sánchez Barreiro. Her research interests encompass nanomedicine, biomaterials engineering, and mucosal drug delivery. She has pioneered studies on protamine nanocapsules, chitosan-based systems, and polyphosphazene derivatives for targeted drug delivery. Her work addresses challenges in overcoming biological barriers (e.g., nasal-to-brain, pulmonary, intestinal) and enhancing therapeutic efficacy through nanoparticle design. Notable contributions include the development of semisynthetic pneumococcal nanovaccines, hybrid peptide-polymer platforms for cancer immunotherapy, and lymphatic-targeted anticancer nanocarriers. Her articles highlight advancements in gene delivery for glioblastoma, ocular tumor treatment, and macrophage-targeted pulmonary therapies. While no specific awards are listed, her prolific publication record (spanning 2002–2025) reflects sustained innovation in pharmaceutical nanotechnology. She collaborates widely on projects integrating biomaterials, molecular medicine, and translational drug delivery systems. Her lab (NANOBIOFAR research group) focuses on translational nanomedicine, emphasizing practical applications such as ready-to-use dry powders for pulmonary delivery and plant-derived sporopollenin microcapsules for drug encapsulation. Current work includes optimizing nanoparticle stability, improving vaccine adjuvants, and addressing barriers in intestinal and transmucosal drug absorption.

• Pharmacology
• Marine Biotechnology
• Virology
• +۳ مورد دیگر

Raquel Lama Lopez is a Juan de la Cierva-former researcher affiliated with the Department of Pharmacology, Pharmacy and Pharmaceutical Technology at the University of Santiago de Compostela (USC). She operates within the Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), focusing on pharmacological and immunological approaches to marine/aquaculture disease control. University: University of Santiago de Compostela Department: Pharmacology, Pharmacy and Pharmaceutical Technology Research Center: CIMUS Her research spans multiple domains: (1) Marine Immunology - identifying novel fish-specific immune proteins like Igldcp and NK-lysin for antiviral/antiparasitic applications, (2) Pharmacological Modulation - investigating anti-inflammatory compounds (e.g., AG5) that preserve innate immunity, (3) Viral Disease Modeling - using zebrafish and turbot models to study nodavirus and rhabdovirus infections, and (4) Biomaterials Development - creating 3D-printed scaffolds for bone tissue engineering with sterilization analysis. Publication trends show a strong emphasis on fish immunology , antiviral mechanisms , marine biotechnology applications, and biomaterials research. Her work combines molecular biology techniques with in vivo model systems to address both aquaculture challenges and broader biomedical questions. Her doctoral thesis at USC (2021) focused on developing new strategies for controlling viral diseases in aquaculture. She has contributed to understanding host-pathogen interactions in fish species through transcriptomic analyses and explored natural products from cyanobacteria for antiviral activity against fish pathogens.

• Oral Microbiome
• Health Literacy
• Dental Caries
• +۱۲ مورد دیگر

Maria José Correia is an Associate Professor at the Faculty of Dental Medicine, Universidade Católica Portuguesa, and a researcher at the Center for Interdisciplinary Research in Health (CIIS). She is actively involved in multiple research projects and supervises PhD students, focusing on oral microbiome, health literacy, and precision diagnostics. Her research interests span oral microbiome , health literacy , dental caries , proteomics , bioinformatics , and systematic reviews . She explores the connections between oral health and systemic conditions such as inflammatory bowel disease and diabetes, emphasizing non-invasive diagnostics and preventive strategies. Recent publications show a strong trend in systematic reviews and clinical studies on topics like probiotics in caries management, white spot lesion treatments, salivary biomarkers, and the impact of service-learning in dental education. Her work integrates molecular techniques with community-based health promotion. Scientific Awards: Bons, maus e vilões entre dentes (Honorary award, 2021) Laura Rubio Award for Service-Learning Projects (2023) She has led and participated in numerous research projects, including OralTherm: Oral Health through Thermal Water , SPRINT: Saliva for Precision Diagnosis , and InDig: Innovation and digital teaching technologies in Dental Medicine . Her collaborative network includes researchers across microbiology, nutrition, and public health. She is also engaged in educational innovation and community outreach, promoting oral health literacy among vulnerable populations through service-learning initiatives.

Justin Balkoمشاهده پروفایل

استاد

• Cancer Immunotherapy
• Oncology
• Hematology
• +۵ مورد دیگر

Justin Balko is a Professor of Medicine in the Hematology and Oncology Division at Vanderbilt University School of Medicine. He is based at the Vanderbilt-Ingram Cancer Center, where his laboratory conducts research focused on enhancing anti-tumor immune responses through multimodal therapeutic strategies. His work bridges preclinical models and clinical translation in cancer immunotherapy. His research interests lie at the intersection of oncology and immunology, particularly in understanding how combination therapies can activate the immune system to target and eliminate cancer cells. Utilizing both in vitro and in vivo mouse models, as well as clinical samples, his lab aims to identify effective immunotherapeutic approaches for cancer treatment. This translational focus positions his work to directly impact patient outcomes in hematologic and solid malignancies. The trends in his research, though specific publications are not listed, indicate a strong emphasis on immuno-oncology, tumor microenvironment modulation, and combination therapy efficacy. His work integrates molecular pharmacology with immunological assessment, reflecting his dual training in pharmacy and biomedical sciences. Scientific awards: No specific awards mentioned in the provided text. Dr. Balko mentors trainees in cancer research and leads a laboratory team focused on therapeutic development. While no formal advisees are listed, his role as a principal investigator suggests involvement in training graduate students, postdoctoral fellows, and clinical researchers. His lab is located in the 777 Preston Research Building, part of the integrated research infrastructure at Vanderbilt University Medical Center.

• Immunology
• Molecular Immunology
• Infectious Diseases
• +۷ مورد دیگر

Jan Petersen is a Research Fellow in the Department of Biochemistry and Molecular Biology at Monash University, within the Faculty of Medicine, Nursing and Health Sciences. His research is centered on molecular and cellular immunology, particularly focusing on T-cell responses to viral and bacterial pathogens. His research interests span Immunology , Infectious Diseases , T-cell Immunity , Immunopeptidomics , HLA Biology , and Viral Epitopes . His work explores how the immune system recognizes conserved epitopes in pathogens such as influenza B virus and SARS-CoV-2, as well as bacterial toxins like cholesterol-dependent cytolysins. The recent publications highlight a strong trend in understanding immune responses across diverse populations, including First Nations peoples, and the role of genetic polymorphisms in immune receptors like KIR3DL3. His research combines structural biology, immunogenetics, and clinical immunology to uncover mechanisms of broad-spectrum immunity. Jan Petersen has no listed scientific awards in the provided text. He collaborates extensively with leading immunologists including James Rossjohn, Anthony W. Purcell, and Katherine Kedzierska. While no direct mention of student supervision or grants is made, his active publication record in top-tier journals suggests involvement in major research initiatives and team-based science. He is part of a dynamic research network at Monash University focused on infectious disease immunity, antigen presentation, and immune modulation in both viral and bacterial contexts.

Inez Schoenmakersمشاهده پروفایل

مدرس ارشد

• Bone Health
• Vitamin D Metabolism
• Calcium and Phosphate Metabolism
• +۷ مورد دیگر

Inez Schoenmakers is a Senior Lecturer at the Norwich Medical School, Faculty of Medicine and Health Sciences, University of East Anglia, UK. She joined UEA in 2016 after working at MRC-Human Nutrition Research in Cambridge. Her work spans clinical and nutritional research with a focus on bone health, vitamin D metabolism, and mineral homeostasis. Education: BSc in Health Sciences, University of Maastricht, The Netherlands MSc in Health Sciences/Medical Biology, University of Maastricht, The Netherlands PhD, Utrecht University, The Netherlands Her research investigates the metabolic underpinnings of bone health across the lifespan, particularly in the context of aging, kidney function, nutrition, ethnicity, and genetic factors. She utilizes RCTs, stable isotope methods, and observational studies in both healthy individuals and patient groups. Her work is highly relevant to conditions involving the renal-bone axis and metabolic bone diseases. The trends in her recent publications highlight a strong focus on vitamin D’s role in bone and mineral metabolism, especially in renal impairment and aging populations. Her work spans clinical observations, pharmacological analysis, and public health implications, appearing in top journals such as Nature Reviews Endocrinology , JAMA , and Age and Ageing . Professional Memberships: American Society for Bone and Mineral Research Bone Research Society She has received research funding from the Medical Research Council, Biotechnology and Biological Sciences Research Council, Academy of Medical Sciences, and Arthritis Research UK. She also provides expert consultation for collaborative projects and governmental bodies, including the WHO. She is currently supervising PhD projects on dietary strategies to protect bone health in renal disease and is accepting new PhD students. She is an active member of research networks involving musculoskeletal medicine, nutrition, and preventive medicine, and contributes to public understanding through media engagement on vitamin D and bone health.

• Chronic Rhinosinusitis
• Olfactory Dysfunction
• Vitamin D Metabolism
• +۵ مورد دیگر

Jennifer K. Mulligan is an Associate Professor in the Department of Otolaryngology – Head & Neck Surgery at the University of Florida. She holds multiple leadership roles including Vice Chair for Research, Co-Director of the UF Health Smell Disorders Program, and Director of Resident Research Education. Her academic work focuses on the immunopathogenesis of chronic rhinosinusitis (CRS) and olfactory dysfunction, with a particular interest in vitamin D metabolism, complement system regulation, and epithelial cell biology. Her research employs experimental models and clinical studies to investigate mechanisms underlying sinonasal inflammation and olfactory impairment. Notable contributions include elucidating roles of vitamin D3 in modulating immune responses and epithelial function, and developing biomarker-based endotyping strategies for CRS subtypes. She has pioneered nasal mucus proteomics and olfactory cleft analysis to identify novel therapeutic targets. Dr. Mulligan's grant portfolio includes NIH-funded projects on vitamin D modulation of CRS inflammation, immune responses to SARS-CoV-2 in upper airways, and biologic therapies for nasal polyposis. She leads clinical trials evaluating treatments like dupilumab for smell recovery. Over 100 peer-reviewed publications span immunology, otolaryngology, and translational research methodologies. Her teaching activities include instructing the GMS6847 course on translational research principles. She mentors residents and fellows in surgical research through structured educational programs. Active collaborations involve immunologists, bioengineers, and clinical researchers across multiple institutions.

• Autophagy
• Mitophagy
• Retinal Degeneration
• +۷ مورد دیگر

Patricia Boya is a Full Professor in the Department of Medicine at the University of Fribourg, within the Faculty of Mathematics, Natural Sciences and Medicine. She is a leading researcher in autophagy, mitophagy, and lysosomal biology, with a focus on retinal and neurodegenerative diseases. Her research interests center on the molecular mechanisms of autophagy and mitophagy, particularly their roles in retinal health, aging, neurodegeneration, and cell death. She investigates how mitochondrial dynamics, lysosomal function, and autophagic flux contribute to diseases such as retinitis pigmentosa, glaucoma, ALS, and Parkinson’s. Her work combines molecular biology, cell imaging, and preclinical models to uncover therapeutic targets. The analysis of her recent publications reveals a strong focus on mitophagy regulation, neuroinflammation (especially via the cGAS/STING pathway), and the development of neuroprotective compounds. She has contributed to high-impact reviews and guidelines in autophagy research, and her work spans fundamental mechanisms to translational applications. She is actively involved in scientific leadership, including the "Women in Autophagy" initiative to promote gender equity in science and the "DRIVE" international PhD training program in autophagy. Dr. Boya has published over 150 articles in top journals including Nature , Nature Communications , Autophagy , and Cell Death & Disease . Her work is highly collaborative, involving interdisciplinary teams across Europe. She leads a research group focused on cellular recycling mechanisms and their implications for vision and aging, contributing significantly to the understanding of autophagy in health and disease.

• Developmental Neurobiology
• Neurodegeneration
• Lab-on-Chip Technology
• +۴ مورد دیگر

José Antonio Del Río Fernández is a distinguished Professor and Group Leader at the Institute for Bioengineering of Catalonia (IBEC) , where he directs the Molecular and Cellular Neurobiotechnology group. His work bridges developmental neurobiology , neurodegeneration , and lab-on-chip technology , focusing on diseases like Alzheimer's and Parkinson's . He has been active in academic research for over 30 years, previously affiliated with institutions such as the University of Barcelona , Frankfurt University , and Imperial College London . Education : PhD , University of Barcelona (1994) Research Interests center on neurodegenerative disease mechanisms , particularly the spreading of tau and α-synuclein in conditions like Alzheimer's and Parkinson's, and axon regeneration after CNS injury. His group pioneers lab-on-chip devices to model neurobiological processes and test regenerative therapies. Collaborations span institutions such as Imperial College , i3A, Zaragoza , and Biodonostia Hospital . Scientific Contributions include over 170 publications, with a H-index of 48 (Web of Science) and 55 (Google Scholar), and significant advancements in understanding prion protein interactions in neurodegeneration. His recent work explores optogenetics for axon regeneration and multitarget compounds for Alzheimer's therapy. He has mentored 24 PhD students , 26 Master's students , and 15 postdoctoral fellows , reflecting a strong commitment to academic training. Scientific Awards : Fundación Francisco Cobos CSIC Award (2001) Generalitat of Catalunya Award of Young Researcher (2003) Research Trends demonstrate a focus on neurodegenerative disease mechanisms , lab-on-chip platforms , and axon regeneration strategies . His collaborations with institutions like Imperial College London and University of Zaragoza highlight interdisciplinary approaches integrating biomaterials , optogenetics , and computational modeling .

Michael Chengمشاهده پروفایل

پزشک-پژوهشگر

• Cancer Genomics
• Precision Oncology
• Lung Cancer
• +۳ مورد دیگر

Dr. Michael L. Cheng is a physician scientist at the University of California San Francisco (UCSF) specializing in medical oncology, with a focus on non-small cell lung cancer (NSCLC) and precision oncology . He integrates cancer genomics into clinical practice to tailor treatments using targeted therapies and immunotherapies. Education : BA in Molecular and Cell Biology, University of California, Berkeley MD, University of California, Los Angeles Residency in Internal Medicine, UCSF Fellowship in Medical Oncology, Memorial Sloan Kettering Cancer Center Research Interests center on advancing cancer genomics , developing targeted therapies , and optimizing immunotherapies through clinical trials. His work explores mechanisms of drug resistance, biomarker discovery (e.g., BRCA2 reversion mutations, ATM mutations), and liquid biopsy applications via plasma cfDNA genotyping. Scientific Awards include the Conquer Cancer Foundation of ASCO Career Development Award Alpha Omega Alpha Honor Society PCF Young Investigator Award Phi Beta Kappa Honor Society Key Publications highlight advancements in precision therapies for NSCLC, BET inhibitors for NUT carcinoma, and genomic profiling of treatment resistance mechanisms.

Marc-André Langloisمشاهده پروفایل

استاد

• Molecular Virology
• Intrinsic Immunity
• Retrovirology
• +۷ مورد دیگر

Dr. Marc-André Langlois is a Full Professor in the Department of Biochemistry, Microbiology and Immunology at the University of Ottawa's Faculty of Medicine. He serves as Executive Director of the national Coronavirus Variants Rapid Response Network (CoVaRR-Net) and holds the Faculty of Medicine Chair of Excellence in Pandemic Viruses and Preparedness Research. An expert in molecular virology and intrinsic immunity, his work bridges retrovirology (e.g., HIV) and respiratory virus research (e.g., SARS-CoV-2, influenza), with a focus on host-virus interactions. Executive Director, CoVaRR-Net Faculty of Medicine Chair of Excellence, Pandemic Viruses Canada Research Chair in Molecular Virology and Intrinsic Immunity Member, Royal Society of Canada (College) Research interests center on: Host Intrinsic Immunity: Mechanisms of APOBEC3 proteins in restricting retroviruses like HIV Viral Latency: Role of APOBEC3 mutagenesis in HIV persistence Respiratory Virus Serology: High-throughput antibody assays for SARS-CoV-2 and seasonal coronaviruses Mucosal Immunity: Systemic and mucosal responses to vaccines, including intranasal candidates Recent publications highlight expertise in: Immune imprinting in antigenic variation Cross-neutralization of SARS-CoV-2 via seasonal coronavirus antibodies HIV integration site profiling by APOBEC3 enzymes Development of scalable serology platforms Mucosal vaccine characterization Scientific awards include: Canada Research Chair in Molecular Virology and Intrinsic Immunity Faculty of Medicine Chair of Excellence Member, Royal Society of Canada (College) His Serology and Diagnostics High Throughput Facility executed over 2 million assays during the pandemic, supporting 40+ national studies including Statistics Canada's seroprevalence surveys. Research informs federal decision-making through Health Canada and CIHR collaborations.

Andreas Kastellakisمشاهده پروفایل

دانشیار

• Psychophysiology
• Neuropsychopharmacology
• Behavioral Neuroscience
• +۳ مورد دیگر

Andreas Kastellakis serves as Associate Professor of Psychophysiology at the University of Crete's Department of Psychology since 1992, with prior affiliation as Associate of the Pharmacology Laboratory at the School of Medicine (1993-2021). His academic foundation includes a Biology degree from the University of Patras (1976-1980) followed by a PhD in Physiology (1981-1986) investigating thyroid hormone uptake mechanisms in rat brain. His research program centers on dopaminergic system interactions with thyroid hormones, somatostatin, opioids, and psychostimulants. Employing in vivo microdialysis , immunohistochemistry, HPLC, and behavioral assays, he examines neurochemical, anatomical, and pharmacological parameters in rodent models. Key focus areas include receptor pharmacology in basal ganglia pathways and neurobiological mechanisms of reward processing. Analysis of his 15 most recent publications (2000-2020) reveals persistent investigation into somatostatin receptor subtypes (sst1-sst4), cannabinoid systems, and dopaminergic modulation of motor activity and addiction. His work consistently bridges molecular neuropharmacology with behavioral outcomes, particularly in Parkinson's disease models, substance reinforcement, and stress-neuroendocrine interactions. Dr. Kastellakis has secured significant research funding including the THALES project on Parkinson's pathogenesis (2012-2015), Special Account for Research Grants projects on thyroid hormones (2000-01) and somatostatin (1994-95), and Region of Crete equipment grants (1996, 1999). He teaches undergraduate courses in Neurobiology-Genetics, Behavioral Physiology II, Comparative Psychology, and Stress-Neuroendocrine-Immune Relations, while co-teaching graduate coursework in Neurobiology and Psychopharmacology of Addiction. His laboratory (A1.104, Building A1) operates within the Department's Behavioral Neuroscience facility.

Judith A. Smithمشاهده پروفایل

دانشیار

• Immunology
• Medical Microbiology
• Infectious Diseases
• +۳ مورد دیگر

Judith A. Smith, MD, PhD, serves as an Associate Professor in both the Department of Pediatrics and the Department of Medical Microbiology & Immunology at the University of Wisconsin–Madison School of Medicine and Public Health. Her research focuses on the intersection of cellular stress responses and immune function, particularly examining how the Unfolded Protein Response (UPR) influences immune signaling during infection. Dr. Smith's work primarily investigates how intracellular pathogens like Brucella manipulate the host endoplasmic reticulum stress response to enhance their survival while modulating inflammatory cytokine production. Her laboratory has demonstrated that macrophages undergoing UPR produce amplified type I IFN, TNF-α, and IL-23 in response to infectious stimuli, suggesting UPR functions as a "danger signal" immune amplifier. Focuses on ER stress response (UPR) in immune cells during infection Studies Brucella manipulation of host UPR pathways Investigates cytokine regulation through UPR signaling Examines cross-talk between stress response and immune pathways Her research has important implications for understanding diverse conditions including viral infections, cancer, neurodegenerative diseases, autoimmune disorders, diabetes, and cardiovascular disease. Dr. Smith has secured significant funding including an R21 from NIAID, an R01 renewal for Brucella research, and a substantial Merck grant for respiratory virus research. R21 from National Institutes of Health/National Institute of Allergy and Infectious Diseases Merck grant ($203,983) for epithelial determinants of respiratory syncytial virus Department of Pediatrics Research and Development Award Dr. Smith actively mentors undergraduate researchers through the Hilldale Faculty/Undergraduate Research Fellowship program and contributes to graduate education through the Cellular & Molecular Pathology Graduate Program, Cellular & Molecular Biology Graduate Program, and Microbiology Doctoral Training Program at UW-Madison.